Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BIO 2019
Biotech
Levin and Maraganore on drug pricing and innovation
Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.
Amirah Al Idrus
Jun 14, 2019 11:33am
CEOs weigh in on biotechs going public earlier and earlier
Jun 12, 2019 11:03am
Meet Refuge Biotech and its 'intelligent' cell therapies
Jun 7, 2019 10:39am
BIO: In conversation with Helen Torley, CEO of Halozyme
Jun 7, 2019 9:58am
BIO: In conversation with Emil Kakkis, Ultragenyx CEO
Jun 7, 2019 8:49am
BIO: In conversation with ArunA Bio CEO Sirgo and CSO Stice
Jun 6, 2019 10:15am
